7. Five major drugs under phase III clinical trial for Type-2 diabetes
8.
9.
10.
11.
12.
13.
14.
15. X X The average duration of study is 2 years and 6 months as calculated from www.clinicaltrials.gov Disease Progression Duration of trials Survival (X) X X X Censored
19. The key market players at present are Hoffmann-La Roche, Novo Nordisk, Merck & Co., Novartis Ag, Sanofi-aventis, Eli Lilly & Company and GlaxoSmithKline reinstated by the figure above. Competitive dynamics of the leading players in the global diabetes market, 2005
20. Global* market share of leading insulins (%), 1999-2003 , The leading giant still is the US with more than 50% market share while the Pacific region is still growing owing to the large population of Diabetic patients in Japan and South Asia.
![[object Object],[object Object],[object Object],[object Object],[object Object],Outline](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)